Latest Contribution
Impact of initial management on relapse in Vogt–Koyanagi–Harada syndrome
3 September 2024
| Zina Mobarak
|
EYE - Vitreo-Retinal
In this retrospective, multi-centre, observational study, the impact of the initial management of Vogt-Koyanagi-Harada syndrome (VKHS) was assessed by reviewing the records of all patients diagnosed with VKHS between January 2001 and December 2020 in two French tertiary centres, with...
The use of adalimumab for relapse in patients with Vogt-Koyanagi-Harada disease
2 August 2024
| Zina Mobarak
|
EYE - Vitreo-Retinal
In this retrospective, multi-centre, cohort study, the efficacy and safety of Adalimumab (ADA) treatment for the exacerbation or recurrence of Vogt-Koyanagi-Harada (VKH) patients was assessed by investigating the medical records of patients who had received ADA treatment for more than...
